How Big Is the Candidiasis Market | Trends 2031

Q: How big is the candidiasis market?

The candidiasis market was demonstrated around USD 1.6 billion in 2024 and is projected to reach USD 5.3 billion by 2031.

Q: What drives the candidiasis market growth?

Rising fungal infection rates, increased immunosuppressive treatments, and growing demand for advanced antifungal therapies.

Q: What are the key trends in the candidiasis market?

Development of resistant-strain antifungals, rapid diagnostics, and targeted treatment options are major trends.

Q: Who are the leading players in the candidiasis market?

Top players of market include Pfizer, Astellas, Merck, Scynexis, and Cidara Therapeutics.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5564

Publication Date: Jul 2025

What is the size of the Candidiasis Market?

According to 6Wresearch internal database and industry insights, the Candidiasis Market was estimated at USD 1.6 billion in 2024 and is projected to reach USD 5.3 billion by 2031, growing at a CAGR of 6.1% during the forecast period 2025–2031.

Due to rising incidences of fungal infections, increased use of immunosuppressive therapies, and a growing immunocompromised population, the market is predicted for the substantial growth in the upcoming years.

Key Growth Factors of the Candidiasis Market

Rising prevalence of hospital-acquired and systemic fungal infections
Increased use of broad-spectrum antibiotics and corticosteroids
Growing geriatric and immunocompromised populations
Expansion of antifungal drug development and approvals
Greater awareness of fungal diseases in clinical settings

Candidiasis Market Trends

The candidiasis market is growing over the years with rising demand for broad-spectrum and rapid-acting antifungal drugs. With the time, research is increasing into resistance mechanisms, which leads to the development of new-generation antifungals. Also, clinicians are increasingly using diagnostic tools for early detection and targeted treatment of invasive candidiasis. Collectively, all these trends are reshaping the dynamics of the market.

Emerging Developments in the Candidiasis Market

Candidiasis market is being advanced with emphasizing focus by R&D on novel antifungal agents and drug combinations to combat resistant Candida strains. Further, the market is observed advancements in molecular diagnostics and non-invasive testing are enabling quicker diagnosis and improved patient outcomes. In the coming years, this market is continued to develop and expand its landscape.